{
  "Variants Include": [
    {
      "Gene": "α-SYN",
      "variants": [
        {
          "HGVS": "NM_000301.1:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_000301.1",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        },
        {
          "HGVS": "NM_000301.1:c.90A>G",
          "cDNA Change": {
            "transcript": "NM_000301.1",
            "ref": "A",
            "alt": "G",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_000301.1:c.158T>C",
          "cDNA Change": {
            "transcript": "NM_000301.1",
            "ref": "T",
            "alt": "C",
            "position": "158"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        },
        {
          "HGVS": "NM_000301.1:c.90A>G;NM_000301.1:c.158T>C",
          "cDNA Change": {
            "transcript": "NM_000301.1",
            "ref": "A",
            "alt": "G",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P/A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Lewy body disease",
    "MONDO": "MONDO:0005171"
  },
  "Experiment Method": [
    {
      "Assay Method": "Thioflavin S assay",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "Synuclein-expressing cells",
        "Description": "Assessment of fibril formation in cultured cells"
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000301.1:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "accelerated fibril formation",
          "Result Description": "E46K variant showed increased fibril formation rate"
        },
        {
          "Variant": "NM_000301.1:c.90A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "decelerated fibril formation",
          "Result Description": "A30P variant exhibited reduced fibril formation"
        },
        {
          "Variant": "NM_000301.1:c.158T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "moderate fibril formation",
          "Result Description": "A53T variant showed intermediate fibril formation"
        },
        {
          "Variant": "NM_000301.1:c.90A>G;NM_000301.1:c.158T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "combined fibril formation",
          "Result Description": "A30P/A53T compound variant showed combined fibril formation patterns"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent cell culture replicates"
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample tested in triplicate"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein used as control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-expressing cells used as control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA used for comparison between groups"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fibril formation rate ≥ 50%",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Fibril formation rate ≤ 20%",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Circular dichroism",
      "Material used": {
        "Material Source": "Protein solution",
        "Material Name": "α-synuclein",
        "Description": "Analysis of secondary structure changes"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000301.1:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "accelerated secondary structure change",
          "Result Description": "E46K variant showed increased β-sheet content"
        },
        {
          "Variant": "NM_000301.1:c.90A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "delayed secondary structure change",
          "Result Description": "A30P variant exhibited reduced β-sheet content"
        },
        {
          "Variant": "NM_000301.1:c.158T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "moderate secondary structure change",
          "Result Description": "A53T variant showed intermediate β-sheet content"
        },
        {
          "Variant": "NM_000301.1:c.90A>G;NM_000301.1:c.158T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "combined secondary structure change",
          "Result Description": "A30P/A53T compound variant showed combined secondary structure patterns"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent protein samples"
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample tested in triplicate"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein used as control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-expressing cells used as control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA used for comparison between groups"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "β-sheet content ≥ 20%",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "β-sheet content ≤ 5%",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Photo-induced cross-linking",
      "Material used": {
        "Material Source": "Protein solution",
        "Material Name": "α-synuclein",
        "Description": "Assessment of intermolecular interactions"
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000301.1:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased cross-linking",
          "Result Description": "E46K variant showed increased intermolecular interactions"
        },
        {
          "Variant": "NM_000301.1:c.90A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "decreased cross-linking",
          "Result Description": "A30P variant exhibited reduced intermolecular interactions"
        },
        {
          "Variant": "NM_000301.1:c.158T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "moderate cross-linking",
          "Result Description": "A53T variant showed intermediate intermolecular interactions"
        },
        {
          "Variant": "NM_000301.1:c.90A>G;NM_000301.1:c.158T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "combined cross-linking",
          "Result Description": "A30P/A53T compound variant showed combined intermolecular interaction patterns"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent protein samples"
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample tested in triplicate"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein used as control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-expressing cells used as control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA used for comparison between groups"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cross-linking ≥ 10%",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cross-linking ≤ 2%",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}